All Updates

All Updates

icon
Filter
Product updates
PathAI launches PathExplore, an AI-powered pathology tool
AI Drug Discovery
Apr 4, 2023
This week:
Funding
Samsara Eco raises AUD 100 million in Series A extension round to expand recycling capabilities
Waste Recovery & Management Tech
Today
Partnerships
Carbios and Zhink Group partner to build PET biorecycling plant in China
Waste Recovery & Management Tech
Today
Partnerships
Product updates
Supernal announces S-A2 concept launch and collaboration with Embry-Riddle Aeronautical University
Passenger eVTOL Aircraft
Today
Funding
Antora Energy to receive USD 14.5 million in grant funding
Alternative Energy
Yesterday
Partnerships
Funding
Volkswagen to invest USD 5 billion in Rivian and forms JV
EV Economy
Yesterday
Product updates
HP introduces range of new additive manufacturing solutions at Rapid + TCT convention
Additive Manufacturing
Yesterday
Product updates
Colibrium Additive launches Spectra M Electron Beam Melting System for enhanced solutions
Additive Manufacturing
Yesterday
Product updates
XJet introduces 17-4PH stainless steel to product portfolio for shorter manufacturing time
Additive Manufacturing
Yesterday
Product updates
Axtra3D announces availability of Loctite 3D IND3380 for Lumia X1
Additive Manufacturing
Yesterday
Product updates
Datadog announces Kubernetes Autoscaling
Cloud-native Tech
Yesterday
AI Drug Discovery

AI Drug Discovery

Apr 4, 2023

PathAI launches PathExplore, an AI-powered pathology tool

Product updates

  • AI-powered bioinformatics company PathAI has launched PathExplore, which the company claims is the world’s first AI-powered pathology tool that provides standardized and scalable panel of human interpretable features (HIFs) for analyzing the tumor microenvironment (TME) with deep resolution. It provides oncology drug developers with high resolution of the TME, enabling researchers to unlock insights that will inform the next phase of targeted oncology drug development.

  • PathExplore generates a panel of over 600 quantitative HIFs to analyze the TME with single-cell resolution, producing overlay visualizations of cell types and tissue regions that are accessible on PathAI's AISight Translational Research platform. The AI-powered tool has been trained using more than 6.5 million annotations by pathologists on 66,000 slides. Currently, PathExplore is available for eight cancers, including breast cancer, colorectal cancer, non-small cell lung cancer and pancreatic cancer, with more planned to launch later this year. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.